Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 3—March 2011

Dispatch

Molecular Epidemiology of Mycobacterium tuberculosis, Buenos Aires, Argentina

Ximena GonzaloComments to Author , Marta Ambroggi, Ezequiel Cordova, Tim Brown, Susana Poggi, and Francis Drobniewski
Author affiliations: Author affiliations: Hospital de Infecciosas Francisco Javier Muñiz, Buenos Aires, Argentina (X. Gonzalo, M. Ambroggi, E. Cordova, S. Poggi); Clinical Sciences Research Center, London, UK (T. Brown, F. Drobniewski)

Main Article

Appendix

Table. Drug susceptibility profiles for 57 patients with MDR TB, Buenos Aires, Argentina, June 1, 2006–April 30, 2007*

Patient no. INH Rif P E Str PAS Cs Pto Eto Cm Am Km Cip Ofx Lfx Mfx
1 R R S S R S S S
2 R R R R S
3 R R S S R S S
4 R R R R R S S R R
5 R R R R R S S
6 R R R R R R S S R S S
7 R R R R
8 R R R S R S S R
9 R R S R S S
10 R R R R R R
11 R R R R R S S
12 R R R R R S S
13 R R R R R S S
14 R R S R R S S
15 R R R R R S S S S R R R S S
16 R R R R R S S R R R S S
17 R R R R R S S R
18 R R R R R S S S R R R R S S
19 R R R R R S S S S R R R S S S
20 R R R S R S S S R R R S S
21 R R R R R S S R R R S S S
22 R R R R S S R
23 R R R R R R R R R R
24 R R R R R S R R R S S R S S
25 R R S R R S S S
26 R R R R R S S
27 R R R R R R S R R
28 R R R R R R S R S
29 R R R S S S
30 R R R S S S S S
31 R R S S R S S S
32 R R S S R S S S
33 R R R R S S S
34 R R S R S
35 R R R R S S S S S
36 R R S R S S S
37 R R S S S S
38 R R R S S S S S
39 R R R R R S S R R R
40 R R S R R S S S S S
41 R R R R S S S S
42 R R R R S S R
43 R R S S S S R S S S S S
44 R R R R R R S S
45 R R R R R S S R
46 R R R R R S S R
47 R R S S R S S
48 R R R S S S
49 R R S S R S S S
50 R R R R R R R S R R R S
51 R R S R S S
52 R R S S S S S
53 R R R S S S R R S S
54 R R R R R S S R
55 R R S S
56 R R S S S S S
57 R R S R R S S S

*MDR, multidrug resistant; TB, tuberculosis; INH, isoniazid; Rif, rifampicin; P, pyrazinamide; E, ethambutol; Str, streptomycin; PAS, p-aminosalicylic acid; Cs, cycloserine; Pto, proteonamide; Eto, ethionamide; Cm, capreomycin; Am, amikacin; Km, kanamycin; Cip, ciprofloxacin; Ofx, ofloxacin; Lfx, levofloxacin; Mfx, moxifloxacin; R, resistant; S, susceptible; –, drugs not tested for those strains.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO